Regeneron Pharmaceuticals, Inc
REGN NASDAQ

REGN
Regeneron Pharmaceuticals, Inc NASDAQ
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now

Financial statements

Financial summary of Regeneron Pharmaceuticals, Inc with all the key numbers

The current REGN market cap is 61.49B. The company's EPS TTM is 37.65, dividend yield is 0.00%, and P/E is 16.33. Next Regeneron Pharmaceuticals, Inc earnings date is August 5, the estimation is 17.00.

Earnings
Next:
Income Statement
Balance Sheet
Cash Flow